Prevention and Treatment of Atherosclerosis

This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.

Summarizes the latest studies on the management of cardiovascular risk factors Reviews exhaustively the key recent research into the pathogenesis of atherosclerotic cardiovascular diseases Outlines various strategies of identifying and validating novel targets for prevention and treatment of atherosclerosis This book is open access, which means that you have free and unlimited access

Autorentext
Previous publications in the Handbook of Experimental Pharmacology series co-edited by Prof. Arnold von Eckardstein : Atherosclerosis: Diet and Drugs, 2005, Arnold von Eckardstein; High Density Lipoproteins, 2015, Arnold von Eckardstein, Dimitris Kardassis (eds.), Open Access

Inhalt
Diet, Life Style, Smoking.- Blood Pressure Lowering.- Glycemic Control in Diabetes.- LDL-Cholesterol Lowering.- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation).- Triglyceride Rich Lipoproteins.- HDL.- Lipoprotein(a).- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome.- Nutraceuticals / Functional Food.- Adipose Tissue (WAT, BAT).- Microbiota and Cardiometabolic Disease.- SMCs, Matrix.- Immune Modulation.- NETs and Neutrophils.- Genomic Strategies Towards Identification of Novel Therapeutic Targets.- Non Coding RNAs.- Metabolomics, Lipidomics.- Epigenomics.